Maximum quantity allowed is 999
请选择数量
CAS RN: 93479-97-1 | 產品號碼: G0395
產品號碼 | G0395 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__2__4H__3__4N__4O__5S = 490.62 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 | 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 93479-97-1 |
Reaxys-RN | 7731873 |
PubChem Substance ID | 160870906 |
Merck Index(14) | 4440 |
MDL編號 | MFCD00878417 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 202.0 to 206.0 °C |
性質
熔點 | 204 °C |
水溶性 | Insoluble |
溶解性(可溶於) | Dimethylformamide |
溶解性(不溶於) | Methanol, Ethanol |
GHS
圖形表示 | |
信號詞 | Warning |
危險性說明 | H361 : Suspected of damaging fertility or the unborn child. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相關法規
RTECS # | UX9363950 |
運輸資料
HS編碼* | 2935.90-000 |
Application
Glimepiride: A Sulfonylurea ATP-Dependent K+ Channel Antagonist
Glimepiride (or glimperide) belongs to sulfonylurea antidiabetics which increase the release of insulin from pancreatic B-cells. Sulfonylurea antidiabetics inhibit ATP-gated K+ channels and thereby cause depolarization of the B-cell membrane. The depolarization leads to activation of voltage-dependent Ca channels and Ca2+ influx into the B-cell, and eventually increases insulin release. In addition, extrapancreatic effects may also play a role in the activity of glimepiride. Glimepiride can stimulate glucose transport and lead to increased sensitivity of peripheral tissues to insulin. (The product is for research purpose only.)
References
- Special pharmacology of the new sulfonylurea glimepiride
- The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro
- Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade
- Glimepiride: a review of its use in the management of type 2 diabetes mellitus
- Sulfonylurea stimulation of insulin secretion (a review)
- The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide, or glimperide in plasma
Application
Pharmacology Studies
References
- Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes
- Simultaneous determination of the sulfonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatization
考研文獻
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。